Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $1.58 billion. Its non-GAAP profit of $0.17 per share was 8.4% above analysts’ consensus estimates.
Is now the time to buy AVTR? Find out in our full research report (it’s free for active Edge members).
Avantor (AVTR) Q1 CY2026 Highlights:
- Revenue: $1.58 billion vs analyst estimates of $1.54 billion (flat year on year, 2.7% beat)
- Adjusted EPS: $0.17 vs analyst estimates of $0.16 (8.4% beat)
- Adjusted EBITDA: $219.4 million vs analyst estimates of $207.9 million (13.9% margin, 5.5% beat)
- Operating Margin: 6.3%, down from 9.3% in the same quarter last year
- Organic Revenue fell 4.1% year on year (beat)
- Market Capitalization: $5.31 billion
StockStory’s Take
Avantor's first quarter results were met with a negative market reaction, as investors focused on persistent margin pressures and flat revenue growth. Management attributed the quarter’s performance to operational improvements in both the VWR Distribution & Services and Bioscience & Medtech Products (BMP) segments. CEO Emmanuel Ligner noted that stabilization in VWR and improved execution in process chemicals within BMP helped offset ongoing softness in Europe and weather-related disruptions in the U.S. Ligner commented, “Our team has a more intense focus on serving customers and we are taking a data-driven approach to user their performance.”
Looking ahead, Avantor's guidance relies on continued operational improvements, enhanced leadership, and a focus on returning to organic revenue growth in the second half of the year. Management expects margin recovery as cost initiatives take hold and the impact of recent segment reorganizations becomes more visible. CFO Brent Jones emphasized that inflationary headwinds related to the Middle East conflict are being actively managed, stating, “We have established a task force whose responsibility is to identify, monitor and mitigate these inflationary headwinds.” The company is also banking on positive momentum from its digital platform upgrades and new talent additions to drive recovery across both major business divisions.
Key Insights from Management’s Remarks
Management credited operational execution, leadership changes, and digital investments as key to stabilizing performance and supporting the outlook for the rest of the year.
-
Leadership refresh underway: Avantor replaced approximately 25% of its senior leadership team, including new hires for Chief Operating Officer, Chief Procurement Officer, Chief Digital Officer, and a new head of BMP. These changes are intended to accelerate execution of the company’s Revival program and improve accountability across the organization.
-
VWR segment stabilization: The VWR Distribution & Services business, which faced prior market share losses and European softness, showed signs of stabilization in Q1. The relaunch and upgrades to the vwr.com e-commerce platform contributed to improved traffic, conversion, and early revenue growth, especially in the U.S. and Europe.
-
BMP operational improvements: Process chemicals within the Bioscience & Medtech Products segment delivered double-digit order and revenue growth, even as other BMP units faced tough year-over-year comparisons due to customer order timing. Management pointed to a positive book-to-bill ratio (over 1.1x) as evidence of a recovering order pipeline.
-
Productivity and automation initiatives: Avantor implemented over 8 weeks of “kaizen” (continuous improvement) events and sanctioned 12 new capital projects, including modular automation at a North American site. These efforts are expected to lower costs, improve throughput, and support future growth.
-
Inflation and cost management: A dedicated task force and new procurement leadership are addressing inflationary pressures, particularly those linked to global events. The company estimates a $10–$20 million operating income headwind from these factors for the full year, but believes mitigation strategies are in place.
Drivers of Future Performance
Avantor’s outlook centers on continued operational improvements, the impact of new leadership, and gradual stabilization across segments.
-
Segment recovery timing: Management expects the VWR business to have reached its low point in Q1, with gradual improvement and a return to positive organic revenue growth in the second half of the year. The BMP segment is expected to bottom in Q2, with recovery driven by process chemical demand and normalization of customer ordering patterns.
-
Margin improvement initiatives: Cost reduction efforts—including automation, productivity programs, and better fixed cost absorption—are expected to support sequential margin improvement as the year progresses. Management noted that price increases earlier in the year and ongoing efforts to manage freight and input costs should further aid gross margin recovery.
-
Risks from inflation and global supply chain: The company acknowledges continued risk from inflationary pressures linked to geopolitical events, particularly in transportation and raw materials costs. Avantor’s ability to pass through surcharges to customers varies by geography, and management is closely monitoring the situation to limit negative impacts.
Catalysts in Upcoming Quarters
Going forward, the StockStory team will be watching (1) the pace of recovery in VWR’s organic growth rates and stabilization in Europe, (2) sequential improvement in BMP demand and the impact of process chemical orders, and (3) the effectiveness of margin improvement initiatives, including automation projects and procurement strategies. The successful integration of new leadership and execution of digital upgrades will also be critical signposts to track.
Avantor currently trades at $7.81, in line with $7.86 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.